Abnormal dietary fatty acid metabolic partitioning in insulin resistance and Type 2 diabetes

Clinical Lipidology

Volumn 6, Issue 6, 2011, Pages 703-716

  Carpentier, André C ^a   Labbé, Sébastien M ^a   Grenier Larouche, Thomas ^a   Noll, Christophe ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

insulin resistance; lipid metabolism; lipotoxicity; metabolism; nonesterified fatty acid; postprandial; triglyceride; Type 2 diabetes

Indexed keywords

CHYLOMICRON; FATTY ACID; HEPATOCYTE NUCLEAR FACTOR 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN; LINOLEIC ACID; LIVER X RECEPTOR; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEARIC ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; DIABETOGENESIS; FAT INTAKE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 82755161102     PISSN: 17460875     EISSN: 17584302     Source Type: Journal    
DOI: 10.2217/clp.11.60     Document Type: Review

References (117)

1. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of Type 2 diabetes. Diabetes 51(1), 7-18 (2002).
2. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87(7), 3023-3028 (2002). (Pubitemid 34816338)
3. McGavock JM, Lingvay I, Zib I et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116(10), 1170-1175 (2007). (Pubitemid 47360218)
4. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with Type 2 diabetes. N. Engl. J. Med. 350(7), 664-671 (2004). (Pubitemid 38364625)
5. Kotronen A, Yki-Jarvinen H, Sevastianova K et al. Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome. Obesity.(Silver Spring) 19(1), 23-28 (2010).
6. Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF. Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies. Am. J. Physiol. Endocrinol. Metab. 300(2), E255-E262 (2011).
7. Bachmann OP, Dahl DB, Brechtel K et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50(11), 2579-2584 (2001). (Pubitemid 33642777)
8. Westerbacka J, Lammi K, Hakkinen AM et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J. Clin. Endocrinol. Metab. 90(5), 2804-2809 (2005). (Pubitemid 40686327)
9. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5(6), 426-437 (2007). (Pubitemid 46825495)
10. Badman MK, Kennedy AR, Adams AC, Pissios P, Maratos-Flier E. A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independent of weight loss. Am. J. Physiol. Endocrinol. Metab. 297(5), E1197-E1204 (2009).
11. Amaro A, Fabbrini E, Kars M et al. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology 139(1), 149-153 (2010).
12. Verna EC, Berk PD. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin. Liver Dis. 28(4), 407-426 (2008).
13. van Loon LJ, Koopman R, Manders R, van der WW, van Kranenburg GP, Keizer HA. Intramyocellular lipid content in Type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am. J. Physiol. Endocrinol. Metab. 287(3), E558-E565 (2004). (Pubitemid 39095892)
14. Liu L, Shi X, BharadwaJ. KG et al. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J. Biol. Chem. 284(52), 36312-36323 (2009).
15. Li LO, Klett EL, Coleman RA. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. Biochim. Biophys. Acta 1801(3), 246-251 (2010).
16. Chavez JA, Summers SA. Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochim. Biophys. Acta 1801(3), 252-265 (2010).
17. Muoio DM. Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? Biochim. Biophys. Acta 1801(3), 281-288 (2010
18. Groop LC, Bonadonna RC, Del Prato S et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J. Clin. Invest. 84, 205-213 (1989). (Pubitemid 19170111)
19. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J. Clin. Invest. 113(11), 1582-1588 (2004). (Pubitemid 39071681)
20. Jocken JW, Goossens GH, van Hees AM et al. Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men. Diabetologia 51(2), 320-327 (2008).
21. Bickerton AS, Roberts R, Fielding BA et al. Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 51(8), 1466-1474 (2008).
22. Carpentier A, Frisch F, Cyr D et al. On the suppression of plasma non-esterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Am. J. Physiol. Endocrinol. Metab. 289(5), E849-E856 (2005). (Pubitemid 41504385)
23. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50(7), 1612-1617 (2001). (Pubitemid 33639602)
24. Brassard P, Frisch F, Lavoie F et al. Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of Type 2 diabetes. J. Clin. Endocrinol. Metab 93(3), 837-844 (2008). (Pubitemid 351398561)
25. Lavoie F, Frisch F, Brassard P et al. Relationship between total and high molecular weight adiponectin levels and plasma nonesterified fatty acid tolerance during enhanced intravascular triacylglycerol lipolysis in men. J. Clin. Endocrinol. Metab. 94(3), 998-1004 (2009).
26. Hosogai N, Fukuhara A, Oshima K et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56(4), 901-911 (2007). (Pubitemid 46525054)
27. Nguyen MT, Satoh H, Favelyukis S et al. JNK and TNF-a mediated free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280(42), 35361-35371 (2005). (Pubitemid 41532725)
28. Carpentier AC, Bourbonnais A, Frisch F, Giacca A, Lewis GF. Plasma nonesterified fatty acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index. J. Clin. Endocrinol. Metab. 95(3), 1256-1264 (2010).
29. Miles JM, Wooldridge D, Grellner WJ. et al. Nocturnal and postprandial free fatty acid kinetics in normal and Type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 52(3), 675-681 (2003). (Pubitemid 36323574)
30. Normand-Lauziere F, Frisch F, Labbe SM et al. Increased postprandial nonesterified fatty acid appearance and oxidation in Type 2 diabetes is not fully established in offspring of diabetic subjects. PLoS ONE 5(6), E10956 (2010).
31. Ravikumar B, Carey PE, Snaar JE et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and Type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 288(4), E789-E797 (2005 (Pubitemid 40397216)
32. McQuaid SE, Manolopoulos KN, Dennis AL, Cheeseman J, Karpe F, Frayn KN. Development of an arterio-venous difference method to study the metabolic physiology of the femoral adipose tissue depot. Obesity (Silver Spring) 18(5), 1055-1058 (2010).
33. Marin P, Rebuffe-Scrive M, Bjorntorp P. Uptake of triglyceride fatty acids in adipose tissue in vivo in man. Eur. J. Clin. Invest. 20(2), 158-165 (1990). (Pubitemid 20126654)
34. Romanski SA, Nelson RM, Jensen MD. Meal fatty acid uptake in human adipose tissue: technical and experimental design issues. Am. J. Physiol. Endocrinol. Metab. 279(2), E447-E454 (2000).
35. Marin P, Oden B, Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J. Clin. Endocrinol. Metab. 80(1), 239-243 (1995).
36. Bickerton AS, Roberts R, Fielding BA et al. Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56(1), 168-176 (2007).
37. McQuaid SE, Humphreys SM, Hodson L, Fielding BA, Karpe F, Frayn KN. Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids. Diabetes 59(10), 2465-2473 (2010).
38. Ruge T, Hodson L, Cheeseman J et al. Fasted to fed trafficking of fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage. J. Clin. Endocrinol. Metab. 94(5), 1781-1788 (2009).
39. Summers LK, Barnes SC, Fielding BA et al. Uptake of individual fatty acids into adipose tissue in relation to their presence in the diet. Am. J. Clin. Nutr. 71(6), 1470-1477 (2000). (Pubitemid 30395893)
40. DeLany JP, Windhauser MM, Champagne CM, Bray GA. Differential oxidation of individual dietary fatty acids in humans. Am. J. Clin. Nutr. 72(4), 905-911 (2000).
41. Votruba SB, Jensen MD. Sex-specific differences in leg fat uptake are revealed with a high-fat meal. Am J. Physiol. Endocrinol. Metab. 291(5), E1115-E1123 (2006).
42. Santosa S, Hensrud DD, Votruba SB, Jensen MD. The influence of sex and obesity phenotype on meal fatty acid metabolism before and after weight loss. Am. J. Clin. Nutr. 88(4), 1134-1141 (2008).
43. Romanski SA, Nelson RM, Jensen MD. Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am. J. Physiol. Endocrinol. Metab. 279(2), E455-E462 (2000).
44. Jensen MD, Sarr MG, Dumesic DA, Southorn PA, Levine JA. Regional uptake of meal fatty acids in humans. Am. J. Physiol. Endocrinol. Metab. 285(6), E1282-E1288 (2003). (Pubitemid 37464379)
45. Uranga AP, Levine J, Jensen M. Isotope tracer measures of meal fatty acid metabolism: reproducibility and effects of the menstrual cycle. Am. J. Physiol. Endocrinol. Metab. 288(3), E547-E555 (2005). (Pubitemid 40250550)
46. Marin P, Lonn L, Andersson B et al. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J. Clin. Endocrinol. Metab. 81(3), 1018-1022 (1996). (Pubitemid 26083964)
47. Votruba SB, Mattison RS, Dumesic DA, Koutsari C, Jensen MD. Meal fatty acid uptake in visceral fat in women. Diabetes 56(10), 2589-2597 (2007). (Pubitemid 47523267)
48. Horton TJ, Commerford SR, Pagliassotti MJ, Bessesen DH. Postprandial leg uptake of triglyceride is greater in women than in men. Am. J. Physiol. Endocrinol. Metab. 283(6), E1192-E1202 (2002). (Pubitemid 35340626)
49. Mitrou P, Boutati E, Lambadiari V et al. Rates of lipid fluxes in adipose tissue in vivo after a mixed meal in morbid obesity. Int. J. Obes. (Lond.) 34(4), 770-774 (2010).
50. McQuaid SE, Hodson L, Neville MJ et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 60(1), 47-55 (2011
51. Duez H, Pavlic M, Lewis GF. Mechanism of intestinal lipoprotein overproduction in insulin resistant humans. Atheroscler. Suppl. 9(2), 33-38 (2008).
52. Medina-Gomez G, Gray SL, Yetukuri L et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 3(4), E64 (2007).
53. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective. Biochim. Biophys. Acta 1801(3), 338-349 (2010).
54. Spalding KL, Arner E, Westermark PO et al. Dynamics of fat cell turnover in humans. Nature 453(7196), 783-787 (2008). (Pubitemid 351793777)
55. Veilleux A, Caron-Jobin M, Noel S, Laberge PY, Tchernof A. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes 60(5), 1504-1511 (2011).
56. Arner E, Westermark PO, Spalding KL et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59(1), 105-109 (2010).
57. Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc. Natl Acad. Sci. USA 107(42), 18226-18231 (2010).
58. Tchoukalova YD, Koutsari C, Votruba SB et al. Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring) 18(10), 1875-1880 (2010).
59. Lonn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of Type 2 diabetes in women. FASEB J. 24(1), 326-331 (2010).
60. Arner P, Arner E, Hammarstedt A, Smith U. Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS ONE 6(4), E18284 (2011).
61. van Tienen FH, Van Der Kallen CJ, Lindsey PJ, Wanders RJ, van Greevenbroek MM, Smeets HJ. Preadipocytes of Type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity. Int. J. Obes. (Lond.) 35(9), 1154-1164 (2011).
62. McLaughlin T, Sherman A, Tsao P et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 50(8), 1707-1715 (2007). (Pubitemid 47036653)
63. McLaughlin T, Deng A, Yee G et al. Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia 53(2), 369-377 (2010).
64. Kursawe R, Eszlinger M, Narayan D et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 59(9), 2288-2296 (2010).
65. Liu A, McLaughlin T, Liu T et al. Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women. Obes. Surg. 19(11), 1564-1573 (2009).
66. Muller G, Schneider M, Biemer-Daub G, Wied S. Upregulation of lipid synthesis in small rat adipocytes by microvesicle-associated CD73 from large adipocytes. Obesity.(Silver Spring) 19(8), 1531-1544 (2011).
67. Labbe SM, Croteau E, Grenier-Larouche T et al. Normal postprandial nonesterified fatty acid uptake in muscles despite increased circulating fatty acids in Type 2 diabetes. Diabetes 60(2), 408-415 (2011).
68. Xiao C, Giacca A, Carpentier A, Lewis GF. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia 49, 1371-1379 (2006).
69. Frayn KN, Hodson L, Karpe F. Dietary fat and insulin sensitivity. Diabetologia 53(5), 799-801 (2010).
70. Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 1801(3), 209-214 (2010).
71. Benoit SC, Kemp CJ, Elias CF et al. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. J. Clin. Invest. 119(9), 2577-2589 (2009).
72. Jump DB. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 13(2), 155-164 (2002). (Pubitemid 34280767)
73. Clarke SD. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol. 15(1), 13-18 (2004). (Pubitemid 39118012)
74. Nunn AV, Bell J, Barter P. The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance. Nucl. Recept. 5(1), 1 (2007).
75. Timlin MT, Parks EJ. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. Am. J. Clin. Nutr. 81(1), 35-42 (2005). (Pubitemid 43073373)
76. Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 91(4), 1446-1452 (2006).
77. Vedala A, Wang W, Neese RA, Christiansen MP, Hellerstein MK. Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J. Lipid Res. 47(11), 2562-2574 (2006). (Pubitemid 44936117)
78. Marques-Lopes I, Ansorena D, Astiasaran I, Forga L, Martinez JA. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. Am. J. Clin. Nutr. 73(2), 253-261 (2001). (Pubitemid 32109853)
79. Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am. J. Clin. Nutr. 93(5), 1048-1052 (2011).
80. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115(5), 1343-1351 (2005). (Pubitemid 40629054)
81. Le KA, Ith M, Kreis R et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of Type 2 diabetes. Am. J. Clin. Nutr. 89(6), 1760-1765 (2009
82. Lowell BB, Shulman GI. Mitochondrial dysfunction and Type 2 diabetes. Science 307(5708), 384-387 (2005). (Pubitemid 40139974)
83. Schrauwen P, Schrauwen-Hinderling V, Hoeks J, Hesselink MK. Mitochondrial dysfunction and lipotoxicity. Biochim. Biophys. Acta 1801(3), 266-271 (2010).
84. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F. Patients with Type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50(4), 790-796 (2007). (Pubitemid 46355830)
85. Turner N, Bruce CR, Beale SM et al. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56(8), 2085-2092 (2007). (Pubitemid 47195821)
86. Hancock CR, Han DH, Chen M et al. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc. Natl. Acad. Sci. USA 105(22), 7815-7820 (2008). (Pubitemid 351872721)
87. Nair KS, Bigelow ML, Asmann YW et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57(5), 1166-1175 (2008).
88. Holloszy JO. Skeletal muscle mitochondrial deficiency does not mediate insulin resistance. Am. J. Clin. Nutr. 89(1), 463S-466S (2009).
89. Maffeis C, Armellini F, Tato L, Schutz Y. Fat oxidation and adiposity in prepubertal children: exogenous versus endogenous fat utilization. J. Clin. Endocrinol. Metab. 84(2), 654-658 (1999). (Pubitemid 29075701)
90. Hodson L, McQuaid SE, Humphreys SM et al. Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation? Am. J. Physiol. Endocrinol. Metab. 299(4), E584-E592 (2010).
91. Masding MG, Stears AJ, Burdge GC, Wootton SA, Sandeman DD. Premenopausal advantages in postprandial lipid metabolism are lost in women with Type 2 diabetes. Diabetes Care 26(12), 3243-3249 (2003). (Pubitemid 37466882)
92. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing Type 2 diabetes. Diabetes 50(11), 2548-2554 (2001). (Pubitemid 33642773)
93. Mittendorfer B, Fields DA, Klein S. Excess body fat in men decreases plasma fatty acid availability and oxidation during endurance exercise. Am. J. Physiol. Endocrinol. Metab. 286(3), E354-E362 (2004). (Pubitemid 38292684)
94. Blaak EE, Hul G, Verdich C et al. Fat oxidation before and after a high fat load in the obese insulin-resistant state. J. Clin. Endocrinol. Metab. 91(4), 1462-1469 (2006).
95. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in Type 2 diabetes. Diabetes 51(10), 2944-2950 (2002).
96. Blaak EE, Wagenmakers AJ. The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with Type 2 diabetes and control subjects. Diabetes 51(3), 784-789 (2002). (Pubitemid 34760189)
97. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 94(6), 2349-2356 (1994).
98. Befroy DE, Falk PK, Dufour S et al. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of Type 2 diabetic patients. Diabetes 56(5), 1376-1381 (2007). (Pubitemid 46715630)
99. Heilbronn LK, Gregersen S, Shirkhedkar D, Hu D, Campbell LV. Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of Type 2 diabetes. Diabetes 56(8), 2046-2053 (2007). (Pubitemid 47195816)
100. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 115(25), 3213-3223 (2007). (Pubitemid 47012236)
101. Larsen TS, Aasum E. Metabolic (in)flexibility of the diabetic heart. Cardiovasc. Drugs Ther. 22(2), 91-95 (2008).
102. Menard SL, Croteau E, Sarrhini O et al. Abnormal in vivo myocardial energy substrate uptake in diet-induced Type 2 diabetic cardiomyopathy in rats. Am. J. Physiol. Endocrinol. Metab. 298(5), E1049-E1057 (2010).
103. Knuuti J, Takala TO, Nagren K et al. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia 44(2), 184-187 (2001). (Pubitemid 32156202)
104. Rijzewijk LJ, Jonker JT, van der Meer RW et al. Effects of hepatic triglyceride content on myocardial metabolism in Type 2 diabetes. J. Am. Coll. Cardiol. 56(3), 225-233 (2010).
105. Szendroedi J, Chmelik M, Schmid AI et al. Abnormal hepatic energy homeostasis in Type 2 diabetes. Hepatology 50(4), 1079-1086 (2009).
106. Sunny NE, Satapati S, Fu X et al. Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 298(6), E1226-E1235 (2010).
107. Van HG, Bulow J, Sacchetti M, Al MN, Lyngso D, Simonsen L. Regional fat metabolism in human splanchnic and adipose tissues; the effect of exercise. J. Physiol. 543(Pt 3), 1033-1046 (2002).
108. Merli M, Eriksson LS, Hagenfeldt L, Wahren J. Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis. J. Hepatol. 3(3), 348-355 (1986). (Pubitemid 17227484)
109. Nosadini R, Avogaro A, Trevisan R et al. Acetoacetate and 3-hydroxybutyrate kinetics in obese and insulin-dependent diabetic humans. Am. J. Physiol. 248(5 Pt 2), R611-R620 (1985). (Pubitemid 15030663)
110. Soeters MR, Sauerwein HP, Faas L et al. Effects of insulin on ketogenesis following fasting in lean and obese men. Obesity (Silver Spring) 17(7), 1326-1331 (2009).
111. Koves TR, Ussher JR, Noland RC et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7(1), 45-56 (2008).
112. Adams SH, Hoppel CL, Lok KH et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in Type 2 diabetic African-American women. J. Nutr. 139(6), 1073-1081 (2009).
113. Huffman KM, Shah SH, Stevens RD et al. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32(9), 1678-1683 (2009).
114. Kien CL, Everingham KI, Stevens D, Fukagawa NK, Muoio DM. Short-term effects of dietary fatty acids on muscle lipid composition and serum acylcarnitine profile in human subjects. Obesity (Silver Spring) 19(2), 305-311 (2010).
115. Meikle SR, Kench P, Kassiou M, Banati RB. Small animal SPECT and its place in the matrix of molecular imaging technologies. Phys. Med. Biol. 50(22), R45-R61 (2005). (Pubitemid 41566715)
116. Labbe SM, Grenier-Larouche T, Croteau E et al. Organ-specific dietary fatty acid uptake in humans using positron emission tomography coupled to computed tomography. Am. J. Physiol. Endocrinol. Metab. 300(3), E445-E453 (2011
117. Ci X, Frisch F, Lavoie F et al. The effect of insulin on the intracellular distribution of 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid in rats. Mol. Imaging Biol. 8(4), 237-244 (2006 (Pubitemid 44193420)